Postmenopausal Osteoporosis Clinical Trials

130 clinical trials for Postmenopausal Osteoporosis across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Blackcurrants Modify Gut Microbiota and Reduce Osteoporosis Risk in Postmenopausal Females — RECRUITING · PHASE1
• Can Serum Lumican Level Identify a Hidden Fragility Phenotype Beyond Bone Mineral Density in Postmenopausal Women? — RECRUITING
• Effectiveness and tolerance of antiresorptive drugs in patients with systemic sclerosis and osteoporosis - a prospective multicentre study — RECRUITING
• StrAtegies For Zoledronic Acid Post-dEnosumab Discontinuation in Postmenopausal oSTeoporosis — RECRUITING · PHASE4
• A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Finding Study to Evaluate the Safety, Tolerability and Efficacy of AGA2118 in Postmenopausal Women with Low Bone Mineral Density — RECRUITING · PHASE2
• A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of Odanacatib (MK-0822) on Bone Mineral Density (BMD) and Overall Safety in the Treatment of Osteoporosis in Postmenopausal Women Previously Treated with Alendronate — COMPLETED · PHASE2
• Effect of alendronate on spontaneous osteoclastogenesis in postmenopausal osteoporosis — COMPLETED · PHASE4
• A double-blind, multicentric, multinational randomised study to assess the effects of two years administration of 2 g per day of strontium ranelate versus alendronate 70 mg per week in women with postmenopausal osteoporosis on bone geometry and bone strength measured by peripheral-Quantitative Computed Tomography (p-QCT). — COMPLETED · PHASE3
• A Double-Blind, Randomized, Repeat Dose, Parallel Group Study of Recombinant Human Parathyroid Hormone (rhPTH(1-31)NH2) tablets, or Placebo tablets, Compared to Open Label Forteo in Postmenopausal Women with Osteoporosis — COMPLETED · PHASE2
• A Study to Assess the Safety, Tolerability, and Efficacy of Odanacatib (MK-0822) vs placebo in the Treatment of Women With Osteoporosis — COMPLETED · PHASE2
• A clinical observational study to assess the effectiveness of Strontium Ranelate on bone protection in osteoporotic patients pre-treated with bisphosphonates. — COMPLETED · PHASE4
• A multicentre, double-blind, randomised, active controlled, parallel group, noninferiority study comparing 75mg risedronate dosed on two consecutive days monthly with 5mg daily risedronate in the treatment of postmenopausal osteoporosis as assessed over 24 months — COMPLETED · PHASE3
• Dried Plums and Bone Health in Postmenopausal Women — ACTIVE_NOT_RECRUITING · NA
• Progressive Strength and Balance Exercise for Fall Prevention in Postmenopausal Women With Osteoporosis — COMPLETED · NA
• Feasibility of a Novel Resistance Exercise in Individuals With Osteoporosis — WITHDRAWN · NA
• Strategies for zoledronic acid post-denosumab discontinuation in postmenopausal osteoporosis — TERMINATED · PHASE4
• Anabolic Therapy in Postmenopausal Osteoporosis — ACTIVE_NOT_RECRUITING · PHASE4
• The Comparison of Ibandronate and Zoledronic Acid After Denosumab Discontinuation — NOT_YET_RECRUITING · PHASE4
• A Phase 3 Study to Compare Biosimilar Denosumab With Prolia® — COMPLETED · PHASE3
• A Trial Evaluating Efficacy of AGA2118 in PostMenopausal Women wIth Low Bone MasS (ARTEMIS) — ACTIVE_NOT_RECRUITING · PHASE2
• AGE Burden and Response to Antiresorptive Therapy in Osteoporosis — NOT_YET_RECRUITING
• Relationship Between Periodontal Disease and Postmenopausal Osteoporosis — COMPLETED
• Effect of Supplementation with Specific Bioactive Collagen Peptides on the Progression of Bone Mineral Density in Osteopenia and Preclinical Osteoporosis — OTHER
• Longitudinal observation of drug therapies for osteoporosis using qct — OTHER
• A Study of Romosozumab (EVENITY®) in Postmenopausal Women in India With Osteoporosis at a High Risk of Fracture. — COMPLETED · PHASE4
• Efficacy and Safety of Actonel® After Denosumab Discontinuation in Postmenopausal Osteoporosis Women — COMPLETED · PHASE4
• Blackcurrants Modify Gut Microbiota and Reduce Osteoporosis and CVD Risk — COMPLETED · PHASE1
• A randomized, double-blind, parallel-group, active-controlled comparative study to evaluate the efficacy, safety, pharmacokinetics, and immunogenicity of LY06006 compared with EU-Prolia in postmenopausal women with osteoporosis — OTHER · PHASE3
• A Study to Evaluate the Efficacy, Pharmacodynamics, Safety, and Immunogenicity of FKS518 in Postmenopausal Women With Osteoporosis — COMPLETED · PHASE3
• Clinical Efficacy and Safety Comparative Study Between CMAB807 Injection and Prolia® . — COMPLETED · PHASE3
• A Study to Compare SB16 (Proposed Denosumab Biosimilar) to Prolia® in Postmenopausal Women With Osteoporosis — COMPLETED · PHASE3
• Alendronate in an Weekly Effervescent Tablet Formulation Following Denosumab Discontinuation — COMPLETED
• Comparative Efficacy and Safety Study of RGB-14-P and Prolia® in Women With Postmenopausal Osteoporosis — COMPLETED · PHASE3
• Efficacy and Safety of Romosozumab Treatment in Postmenopausal Women With Osteoporosis — COMPLETED · PHASE3
• Compare the Agility Exercise and Resistance Exercise on Physical Function and Stability in Osteoporotic Women — COMPLETED · NA
• A Study to Evaluate the Safety and Tolerability of MK0217 in Women (0217-219) — COMPLETED · PHASE3
• A Study to Evaluate and Compare Alendronate and Risedronate on Bone Mineral Density in Women With Postmenopausal Osteoporosis (MK-0217-211) — COMPLETED · PHASE3
• How Vertebral Fractures Effect Balance In Postmenopausal Women — COMPLETED
• Treatment Exercises With Core Stability and Dynamic Resistance Exercise for Postmenopausal Women With Osteoporosis — COMPLETED · NA
• A Study of MK-0822 in Postmenopausal Women With Osteoporosis to Assess Fracture Risk (MK-0822-018) — TERMINATED · PHASE3
• Eldecalcitol and Calcitriol in Postmenopausal Women With Low Bone Mineral Density or Mild Osteoporosis — OTHER · PHASE4
• Impact of Ultraviolet Radiation on Bone Density and Muscle Strength in Postmenopausal Women — COMPLETED · NA
• Prevention of Osteoporosis in Breast Cancer Survivors — COMPLETED · NA
• Study to Evaluate the Pharmacokinetics (PK), Pharmacodynamics (PD), and Usability of Abaloparatide-solid Microstructured Transdermal System (sMTS) in Postmenopausal Women With Low Bone Mineral Density (BMD) — COMPLETED · PHASE1
• Bone Modeling Effects of Combined Anabolic/Antiresorptive Administration — COMPLETED · PHASE4
• Efficacy & Safety of Abaloparatide-Solid Microstructured Transdermal System in Postmenopausal Women With Osteoporosis — COMPLETED · PHASE3
• Prevention of Early Postmenopausal Bone Loss With Lactobacillus Reuteri — COMPLETED · NA
• MiDeTe - microRNA Levels Under Denosumab and Teriparatide Therapy in Postmenopausal Osteoporosis — COMPLETED · PHASE4
• Low dose estrogen has no significant effect on bone fracture healing measured by pQCT in postmenopausal women — OTHER
• Efficacy and Safety of Minodronate in Patients With Low Back Pain — OTHER · PHASE4

Refine this search